Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Drug-induced lung disease
    Metin Özkan, MD, Raed A. Dweik, MD and Muzaffar Ahmad, MD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 782-795;

    Early diagnosis is important because stopping the drug usually reverses toxicity, whereas unrecognized toxicity can be progressive and even fatal.

  • You have access
    Systolic ejection murmur presenting with dyspnea on exertion
    B.P. Griffin, Tobias Peikert, MD and Craig R. Asher, MD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 809-814;

    What is the cause of this patient’s cardiac symptoms A self-test.

  • You have access
    Correction
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 746;
  • You have access
    The dangers of self-monitored dieting: What are our patients really doing?
    Cindy L. Moore, MS, RD, LD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 777-781;

    Patient-monitored diets often leave questions of adherence and safety unanswered.

  • What you should know about low-carbohydrate diets
    You have access
    What you should know about low-carbohydrate diets
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 775-776;
  • You have access
    At what level of hyperkalemia or creatinine elevation should ACE inhibitor therapy be stopped or not started?
    Saul Nurko, MD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 754-760;

    These drugs are a double-edged sword: they slow the decline in renal function in many patients, yet reduce renal function in some.

  • You have access
    Physician’s guide to popular low-carbohydrate weight-loss diets
    George L. Blackburn, MD, PhD, Judy C.C. Phillips, MS, RD and Susan Morreale, CHES
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 761-774;

    These diets can take pounds off fast but usually fail in the long term and can jeopardize health.

  • You have access
    Adverse drug reactions and medication errors: Not always a clear distinction
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 739;

    Unrecognized adverse drug reactions can quickly become medication errors.

  • Should amphetamines be added to SSRI therapy to enhance the antidepressant effect?
    You have access
    Should amphetamines be added to SSRI therapy to enhance the antidepressant effect?
    Vivek Singh, MD and Donald A. Malone, MD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 748-749;

    Despite anecdotal reports of an additive effect, no firm conclusions can be drawn.

  • Peripheral vascular disease
    You have access
    Peripheral vascular disease
    Cleveland Clinic Journal of Medicine August 2001, 68 (8) 734;

Pages

  • Previous
  • Next
  • 1
  • …
  • 398
  • 399
  • 400
  • 401
  • 402
  • 403
  • 404
  • 405
  • 406
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire